Related Experiment Videos
Etomidate: an ultrashort-acting nonbarbiturate agent for anesthesia induction
Anesthesia and Analgesia
|March 1, 1976
Summary
Etomidate, a nonbarbiturate hypnotic, is effective for anesthetic induction in adults, acting rapidly with minimal cardiovascular or respiratory effects. While generally safe, potential drawbacks include injection site pain and myoclonia.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Etomidate is an ultrashort-acting nonbarbiturate hypnotic agent.
- Anesthetic induction requires agents with rapid onset and minimal side effects.
Purpose of the Study:
- To evaluate the clinical utility of etomidate for anesthetic induction in adults.
- To assess the safety and efficacy profile of etomidate.
Main Methods:
- Clinical evaluation of etomidate in adult patients undergoing anesthesia.
- Monitoring of onset of sleep, metabolite levels, and cardiovascular/respiratory parameters.
- Assessment of adverse events, including injection site pain and myoclonia.
Main Results:
- Etomidate demonstrated rapid anesthetic induction, with sleep onset within one arm-brain circulation time.
- Metabolite levels peaked approximately 7 minutes postinjection.
- Cardiovascular and respiratory systems were minimally affected.
- No organ toxicity or significant biochemical/hematologic disturbances were observed.
- Principal disadvantages included moderate injection site pain and transient myoclonia.
Conclusions:
- Etomidate is a useful agent for anesthetic induction in adults.
- The drug exhibits a favorable safety profile with minimal impact on vital systems.
- Potential adverse effects such as injection pain and myoclonia should be considered.